Verdeso Foam uses

used by Verdeso Foam

Disonide foam belongs to the group of drugs known as corticosteroids. Disonide foam is no longer produced for sale in Canada. Rotate the can upside down to distribute the foam.

LOW FECTS

The Verdeso (desonide) foam, 0. 05% is a topically (for the skin) applied esteroid for the treatment of inflammations and pruritus due to a number of diseases of the dermis such as hypersensitivity, dermatitis and pruritus. Frequent side affects of Verdeso Foam in the mouth are prick, sting ing, burn, itch, drought, itch, peel or redden at the site of use.

The other side effects of Verdeso Foam are: eczema, uninvited /new coat growing, "hair push" (folliculitis), thin ing/softening of the complexion, coloration of the complexion, pregnancy stripes, dry or flaky complexion, oral eczema or peeling, blistering, incrustation of the affected area. A thin coat of Verdeso Foam should be applied twice a day to the affected areas.

The Verdeso may interfere with other medications. Verdeso Foam should only be used on prescription during gestation. There is no information as to whether this medicine gets into breastmilk when used on the scalp. The Verdeso (Desonide) Foam, 0. 05% Side effect Active Substance Center provides a complete overview of the available information about the possible side effects of taking this medicine.

There is no full listing of side affects and others may appear. Contact your physician for consultation on side effect medications. The FDA can be contacted at 1-800-FDA-1088 to notify you of side effects. Please contact the FDA. Steroid drugs can be ingested through the epidermis, which can lead to side reactions throughout the entire system. Quit using Deonide currently and call your personal physician if you have: blurred vision, or seeing halos around light; unequal heart beats; sleeping issues (insomnia); tiredness.

Stop also using Desonid topically and call your physician immediately if you: show symptoms of dermatitis (swelling, flushing, heat, leachate). Frequent side affects may include: prick or burn of the affected area; pruritus or flushing of the affected area; pruritus or flushing of the affected area; scaling, flaking or dehydrated area; acid, eczema, skin eruption; pregnancy streaks; foliculitis (redness or crust formation around the scalp).

There is no full listing of side affects and others may appear. Contact your physician for consultation on side effect medications. The FDA can be contacted at 1-800-FDA-1088 to notify you of side effects. Please contact the FDA. Due to the fact that studies are performed under very different circumstances, the side effect rate seen in the studies of one medicine cannot be directly comparable to that seen in the studies of another medicine and may not mirror the values seen in actual use.

Side effects were observed in a monitored study of 581 volunteers between the ages of 3 month and 17 years in 6% of VERDESO foam-treated volunteers and 14% of VERDESO automotive foam-treated volunteers. Table 1 lists other frequently reports of side effects of VERDESO Foam and foam vehicles.

Others side effects occured at less than 1.0% rate. Most of the side effects were temporary and light to moderately severe, and they were not affected by sex, breed or aging. Following supplemental side effects have been observed in patients with topically occurring correticosteroids. Those responses are enumerated in an approximately declining order: foliculitis, acne former eruption, hyperpigmentation, perioral dermatitis, hypergic contagious dermatitis, minor infections, stripes andiliaria.

Since these responses are voluntary reports from an unknown populations, it is not always possible to assess their prevalence accurately or to make a cause and effect connection with them. Side effects of the use of VERDESO Foam after registration include: site stimulation, site erythema, site reaction, dermal reaction and facial swollening.

Verdeso Patient Information is provided by Cerner Multum, Inc. and Verdeso Consumer Information is provided by First Databank, Inc.

Mehr zum Thema